ArticleScientific reports2024
Predictive factors influencing hypothyroidism following the radioactive iodine treatment of Graves' disease in different periods.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Outcome of MRI-Guided Single-Dose Iodine-131 for Graves' Hyperthyroidism with Large Goiter.Annals of nuclear medicine · 2026Article
- Non-linear association between thyroid scintigraphy-derived thyroid weight and I-131 treatment efficacy in graves' disease: a multicenter restricted cubic spline and threshold analysis.Frontiers in endocrinology · 2026Article
- Association ofFrontiers in microbiology · 2026Article
- Radioactive Iodine Therapy for Pediatric Graves' Hyperthyroidism.Medical science monitor : international medical journal of experimental and clinical research · 2025Article
- Prediction of total iodine dose of I-131 therapy for Graves' hyperthyroidism achieved remission status: a random forest regressor model approach to assess treatment efficacy.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In China, due to the risks of hypothyroidism after radioiodine treatment, radioiodine is not commonly used as a first-line treatment. In this study, factors influencing the development of hypothyroidism after
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.